| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Dec 14, 2017 |
|||||||||
| Q1 FY18 | $1.36 | $1.34 | $31.81B | $29.40B |
NASDAQ |
||||
| Q4 FY17 | - | - | $12.38B | - |
NASDAQ |
||||
| Q2 FY18 | $0.70 | $0.68 | $9.62B | $9.32B |
NYSE |
||||
Jabil
JBL
|
- | $0.80 | $0.78 | $5.59B | $5.51B |
NYSE |
|||
|
Scholastic
SCHL
|
Q2 FY18 | $1.92 | $1.75 | $598.30M | $654.39M |
NASDAQ |
|||
|
Virco Mfg.
VIRC
|
- | $0.16 | $0.30 | $68.79M | $128.98M |
NASDAQ |
|||
|
Stellar Bancorp
STEL
|
- | $0.45 | $0.43 | $33.26M | - |
NYSE |
|||
|
ESSA Bancorp
ESSA
|
- | $0.19 | - | $17.32M | - |
NASDAQ |
|||
|
Forward Industries
FORD
|
- | $0.20 | - | $6.31M | - |
NASDAQ |
|||
|
BRT Apartments
BRT
|
- | $0.22 | $0.17 | $28.39M | $2.18M |
NYSE |
|||
|
KalVista Pharmaceuticals
KALV
|
- | -$0.50 | -$0.45 | $1.13M | $1.02M |
NASDAQ |
|||
|
Netcapital
NCPL
|
- | $0.72 | - | $24.12K | - |
NASDAQ |
|||
|
PharmaCyte Biotech
PMCB
|
- | -$2.79 | - | - | - |
NASDAQ |
|||
| Show 3 more companies | |||||||||
